Workflow
Can ITGR Stock's Growth Drivers Offset Rising Risks in 2025?
ITGRInteger (ITGR) ZACKS·2025-02-27 14:50

Core Viewpoint - Integer Holdings Corporation (ITGR) demonstrated solid revenue growth in Q4 2024, with revenues of 449.5million,anincreaseof8.8449.5 million, an increase of 8.8% year over year, although EPS of 1.43 missed estimates by 3 cents due to short-term cost pressures [1][2] Financial Performance - Q4 2024 revenues reached 449.5million,markingan8.8449.5 million, marking an 8.8% year-over-year increase [1] - EPS for Q4 2024 was 1.43, missing estimates by 3 cents [1] - For 2025, ITGR projects sales growth of 8-10% and adjusted operating income growth of 11-16% [1] Stock Performance - ITGR's share price has declined by 4.4% since February 20, following the earnings release [2] - Over the past year, ITGR shares have increased by 18%, compared to the industry’s growth of 1.7% [2] - The current P/E forward 12-month ratio for ITGR is 20.9X, below the industry average of 32.01X, but above its five-year median of 18.53X [5] Growth Drivers - Organic sales are expected to grow by 6-8% in 2025, outpacing the estimated market growth of 4-6% [8] - New product launches and strong demand in high-growth segments like electrophysiology and structural heart are key contributors [8] - Recent acquisitions, including Precision Coating for 152millionandVSiParylenefor152 million and VSi Parylene for 28 million, are projected to add 59millioninrevenuesin2025[9]Manufacturingefficienciesareexpectedtodriveadjustedoperatingincomegrowthof111659 million in revenues in 2025 [9] - Manufacturing efficiencies are expected to drive adjusted operating income growth of 11-16% in 2025 [10] - Investments in renal denervation and next-gen cardiac devices position the company well for future demand [11] Challenges - Potential headwinds from new U.S. tariffs on imports could complicate operations, especially with significant manufacturing in Mexico [16] - Initial inefficiencies and workforce training related to scaling new product lines may pressure gross margins in early 2025 [17] Earnings Estimates - Mixed performance in earnings estimates, with Q1 2025 EPS estimate declining by 3% while Q2 improved by 1.4% [12] - Full-year 2025 EPS estimate remains unchanged at 6.01, with projected sales growth of 7.5% and EPS growth of 13.4% [12]